EGM
CAPR icon

Engineers Gate Manager’s Capricor Therapeutics CAPR Stock Holding History

Engineers Gate Manager’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,830
Closed -$1.18M – 2270
2026
Q1 		$1.18M Buy
+38,830
New +$1.03M 0.01% 973
2025
Q2 		– Sell
-22,025
Closed -$209K – 2184
2025
Q1 		$209K Buy
22,025
+10,339
+88% +$144K ﹤0.01% 1879
2024
Q4 		$161K Buy
+11,686
New +$205K ﹤0.01% 1938
2024
Q3 		– Sell
-13,419
Closed -$64K – 2135
2024
Q2 		$64K Buy
+13,419
New +$74.8K ﹤0.01% 1795

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Engineers Gate Manager's CAPR Position: Q2 2026 in Review

Engineers Gate Manager sold out of Capricor Therapeutics (CAPR) in Q2 2026, closing a stake of 38,830 shares — an estimated $1.18M sold.

Engineers Gate Manager first reported a position in CAPR in Q2 2024 and held it in 4 quarters. The position peaked at $1.18M in Q1 2026. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Engineers Gate Manager reported no remaining Capricor Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 38,830 Capricor Therapeutics shares in Q2 2026, an estimated $1.18M.
  • Engineers Gate Manager first reported a position in Capricor Therapeutics in Q2 2024 and held it in 4 quarters.
  • Engineers Gate Manager's Capricor Therapeutics position peaked at $1.18M in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.